Patent: 5,236,838
✉ Email this page to a colleague
Summary for Patent: 5,236,838
| Title: | Enzymatically active recombinant glucocerebrosidase |
| Abstract: | Recombinant enzymatically active glucocerebrosidase is produced by a eukaryotic cell. Also, a cell includes nucleic acid encoding enzymatically active glucocerebrosidase; also a eukaryotic organism contains such a cell. Also, a method for producing enzymatically active glucocerebrosidase includes steps of introducing glucocerebrosidase-encoding nucleic acid into a eukaryotic cell, causing the cell to express glucocerebrosidase, and purifying the glucocerebrosidase from the cell. |
| Inventor(s): | Rasmussen; James (Boston, MA), Barsomian; Gary (Georgetown, MA), Bergh; Michel (Belmont, MA) |
| Assignee: | Genzyme Corporation (Cambridge, MA) |
| Application Number: | 07/748,283 |
| Patent Claims: | see list of patent claims |
Details for Patent 5,236,838
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Genzyme Corporation | CEREZYME | imiglucerase | For Injection | 020367 | May 23, 1994 | ⤷ Start Trial | 2011-08-21 |
| Genzyme Corporation | CEREZYME | imiglucerase | For Injection | 020367 | September 22, 1999 | ⤷ Start Trial | 2011-08-21 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 5,236,838
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Austria | E138686 | ⤷ Start Trial |
| Canada | 2006709 | ⤷ Start Trial |
| Canada | 2339888 | ⤷ Start Trial |
| Germany | 68926569 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
